National Comprehensive Cancer Network
|
|||||
- Educational Events & Programs
- NCCN Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™
- NCCN Annual Congress: Hematologic Malignancies™
- NCCN Congress Series™
- NCCN Guidelines Update Webinar Series™
- NCCN Academy for Excellence & Leadership in Oncology™
- NCCN On-line CME/CE
- NCCN Library of Case Studies™
- NCCN Oncology Case Management Program™
- NCCN Oncology Policy Program
- NCCN International Programs
Recent Updates to NCCN Guidelines®
NCCN Categories of Evidence and Consensus
NCCN Guidelines® Steering Committee
Submission Request to the NCCN Guidelines Panels
Submission Request History
NCCN Guidelines Panels-Meeting Schedule
Permissions Requests
NCCN Compendium®
About the NCCN Compendium®
NCCN Compendium™ Chapters By Disease
Transparency: Process and Recommendations
No Longer Recommended Uses
NCCN Templates®
JNCCN – The Journal of the National Comprehensive Cancer Network
Subscribe Now
FAQ
JNCCN Task Force Supplements
NCCN Guidelines® & Clinical Resources
| |
Commercial SupportThis Congress is supported by educational grants from Amgen, Bayer HealthCare Pharmaceuticals Inc., Bristol-Myers Squibb Company, Celgene Corporation, Cephalon Oncology, Eisai Inc., Genentech BioOncology, Genzyme Oncology, Merck Oncology, MGI PHARMA, INC., Millenium Pharmaceuticals, Inc., Novartis Oncology, Ortho Biotech, Pharmion Corporation, and sanofi-aventis U.S. No personal information is provided to any grant providers. |
E-mail
Print
Mark
Privacy Policy| Legal Notices| Site Map| Contact Us| Help
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved